<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>modification_summary_a_034.html</title>
</head>
<body>
<p>* The company expanded internationally through a UK-based acquisition.</p>
<p>* A new risk was disclosed for UK government payor reimbursement.</p>
<p>* A new risk was identified regarding a Supreme Court healthcare case.</p>
<p>* A new risk was disclosed for potential Texas Medicaid funding deferrals.</p>
<p>* A new risk was added for maintaining future EHR compliance.</p>
<p>* Specific geographic markets are no longer cited as competition risks.</p>
<p>* The discount for uninsured patients was increased from 30% to 60%.</p>
<p>* The company disclosed its ownership of a commercial health insurer.</p>
<p>* Insurance arrangements for new UK operations are now disclosed.</p>
<p>* The composition of Texas Medicaid receivables is newly detailed.</p>
<p>* A new charge was disclosed for a shareholder lawsuit settlement.</p>
<p>* Costs from early debt extinguishment are newly reported.</p>
<p>* Improved performance is newly attributed to the Affordable Care Act.</p>
<p>* The list of states representing significant Medicaid revenue concentration changed.</p>
<p>* The company acquired a commercial health insurer headquartered in Nevada.</p>
<p>* The newly acquired health insurer incurred operating losses during the year.</p>
<p>* The company expanded internationally by acquiring behavioral health facilities in the U.K.</p>
<p>* A new behavioral health facility and outpatient center was acquired in Washington, D.C.</p>
<p>* The explanation for a lower provision for doubtful accounts is now provided.</p>
<p>* A disclosure about rising uninsured patients and collection difficulties was removed.</p>
<p>* The outlook for Medicare IPPS payments shifted from a net increase to a decrease.</p>
<p>* The company notes that Medicare Recovery Audit Contractor reviews are restarting.</p>
<p>* The list of states providing significant Medicaid revenue was updated.</p>
<p>* A new disclosure was added for the Texas DSRIP incentive payment program.</p>
<p>* Texas Medicaid supplemental payments are now discussed as part of a waiver program.</p>
<p>* A new Medicaid hospital supplemental payment program in Nevada was disclosed.</p>
<p>* The start of ACA-mandated DSH payment reductions was delayed again.</p>
<p>* The firm confirmed all acute hospitals met &quot;meaningful use&quot; EHR criteria.</p>
<p>* The EHR incentive program shifted from a net favorable to unfavorable financial impact.</p>
<p>* The schedule and amounts for future DSH funding reductions were revised.</p>
<p>* The maximum penalty under the hospital readmission reduction program was increased.</p>
<p>* A new readmission measure for certain bypass surgeries will be added.</p>
<p>* The company executed a major debt refinancing and capital structure reorganization.</p>
<p>* A new charge was incurred for the early extinguishment of debt.</p>
<p>* The firm provided new explanations for a lower effective tax rate.</p>
<p>* A disclosure on indefinitely reinvested foreign earnings was added.</p>
<p>* Spending on acquisitions of businesses increased significantly.</p>
<p>* The firm expanded internationally by acquiring a UK-based healthcare company.</p>
<p>* The company entered the commercial health insurance market via an acquisition.</p>
<p>* A new open market stock repurchase program was initiated.</p>
<p>* The quarterly cash dividend per share was doubled.</p>
<p>* The borrowing capacity of the accounts receivable securitization program was increased.</p>
<p>* A new category for accrued claims expense was added to contractual obligations.</p>
<p>* Put rights disclosures were updated to include an additional facility under construction.</p>
</body>
</html>
